Asserter profile

CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L.

operating company4 patents now4 ever0 cases filed during tenure1 connections

PTAB exposure

4of this entity’s patents have been challenged at PTAB (4 total proceedings).

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nclaret_european_specialty_lending_iii_r_l["CLARET EUROPEAN SPECIALTY LENDING COMPA…"]
    Nneurent_medical["Neurent Medical Limited"]
    Ntownley_david["TOWNLEY, David"]
    Nneurent_medical -->|"2024 · Security Interest · 11998262"| Nclaret_european_specialty_lending_iii_r_l
    Nneurent_medical -->|"2024 · Security Interest · 12089889"| Nclaret_european_specialty_lending_iii_r_l
    Nneurent_medical -->|"2024 · SECURITY INTEREST · 12096973"| Nclaret_european_specialty_lending_iii_r_l
    Nneurent_medical -->|"2024 · Security Interest · 12096974"| Nclaret_european_specialty_lending_iii_r_l
    Ntownley_david -->|"2024 · Assignment · 11998262"| Nneurent_medical
    Ntownley_david ==>|"⚖️ 2024 · ASSIGNMENT · 12096973"| Nneurent_medical
    Ntownley_david -->|"2024 · Assignment of Assignors Interest · 12096974"| Nneurent_medical
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nclaret_european_specialty_lending_iii_r_l focal
    class Nneurent_medical operating

Patents currently held (4)

Connected entities (1)

Correspondent attorneys (4)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.